<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941184</url>
  </required_header>
  <id_info>
    <org_study_id>19-002489</org_study_id>
    <nct_id>NCT03941184</nct_id>
  </id_info>
  <brief_title>Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity</brief_title>
  <official_title>Determining the Association Between Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This case control study aims to determine whether spontaneous coronary artery dissection
      (SCAD) is associated with autoimmune diseases and to update the incidence of SCAD in a
      population-based cohort.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 1995</start_date>
  <completion_date type="Anticipated">March 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Odds of autoimmune disease in SCAD cases compared to controls</measure>
    <time_frame>Through study completion, or approximately 50 years (average age of study participants)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of SCAD</measure>
    <time_frame>Through study completion, or approximately 50 years (average age of study participants)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SCAD recurrence</measure>
    <time_frame>Through study completion, or approximately 50 years (average age of study participants)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Odds of laboratory markers for autoimmune disease in SCAD cases compared to controls</measure>
    <time_frame>Through study completion, or approximately 50 years (average age of study participants)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Odds of validated rheumatoid arthritis in SCAD cases compared to controls</measure>
    <time_frame>Through study completion, or approximately 50 years (average age of study participants)</time_frame>
    <description>using the Rochester Epidemiology Project Rheumatoid Arthritis cohort</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>SCAD</condition>
  <condition>Addison Disease</condition>
  <condition>Ankylosing Spondylitis</condition>
  <condition>Antiphospholipid Antibody Syndrome</condition>
  <condition>Celiac Disease</condition>
  <condition>Crohn Disease</condition>
  <condition>Dermatomyositis</condition>
  <condition>Polymyositis</condition>
  <condition>Guillain-Barre Syndrome</condition>
  <condition>Hepatitis, Autoimmune</condition>
  <condition>Graves Disease</condition>
  <condition>Hashimoto Thyroiditis</condition>
  <condition>Multiple Sclerosis</condition>
  <condition>Myasthenia Gravis</condition>
  <condition>Pernicious Anemia</condition>
  <condition>Polymyalgia Rheumatica</condition>
  <condition>Primary Biliary Cirrhosis</condition>
  <condition>Psoriasis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Systemic Sclerosis</condition>
  <condition>Sj√∂gren Syndrome</condition>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Takayasu Arteritis</condition>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Ulcerative Colitis</condition>
  <condition>Uveitis</condition>
  <condition>Vasculitis</condition>
  <condition>Vitiligo</condition>
  <condition>Raynaud</condition>
  <arm_group>
    <arm_group_label>SCAD cases</arm_group_label>
    <description>SCAD cases will be identified based on presence of at least one diagnosis code for SCAD followed by manual verification by a trained individual, OR, inclusion in the previously validated SCAD cohort (Tweet 2012).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls without SCAD</arm_group_label>
    <description>Potential controls will be identified based on absence of any SCAD diagnosis codes.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The Rochester Epidemiology Project (REP) is a population-based cohort that includes medical
        record data for over 500,000 unique individuals who resided in Olmsted County at some point
        between 1966 and the present, and received health care for any reason within the system
        (St. Sauver 2012).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults age 18 to 110

          -  Residence in Olmsted County. Note: if sufficient numbers cannot be reached using only
             Olmsted County, will expand to the 27-county region.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa L Kronzer, MD, MSCI</last_name>
      <phone>507-284-2511</phone>
      <email>kronzer.vanessa@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Vanessa L Kronzer, MD, MSCI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marysia S Tweet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cynthia S Crowson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Myasoedova, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicholas Tan, MD MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Davis, MD MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sharonne N Hayes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajiv Gulati, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/SCAD</url>
    <description>Mayo Clinic SCAD Research Program</description>
  </link>
  <link>
    <url>https://clinicaltrials.gov/ct2/show/NCT01429727</url>
    <description>The &quot;Virtual&quot; Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry</description>
  </link>
  <link>
    <url>https://clinicaltrials.gov/ct2/show/NCT01427179</url>
    <description>Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)</description>
  </link>
  <reference>
    <citation>Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, Gersh BJ, Khambatta S, Best PJ, Rihal CS, Gulati R. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012 Jul 31;126(5):579-88. doi: 10.1161/CIRCULATIONAHA.112.105718. Epub 2012 Jul 16.</citation>
    <PMID>22800851</PMID>
  </reference>
  <reference>
    <citation>McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006 Aug;3(8):e297.</citation>
    <PMID>16942393</PMID>
  </reference>
  <reference>
    <citation>St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Pankratz JJ, Brue SM, Rocca WA. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012 Dec;41(6):1614-24. doi: 10.1093/ije/dys195. Epub 2012 Nov 18.</citation>
    <PMID>23159830</PMID>
  </reference>
  <reference>
    <citation>Tweet MS, Kok SN, Hayes SN. Spontaneous coronary artery dissection in women: What is known and what is yet to be understood. Clin Cardiol. 2018 Feb;41(2):203-210. doi: 10.1002/clc.22909. Epub 2018 Mar 1. Review.</citation>
    <PMID>29493808</PMID>
  </reference>
  <reference>
    <citation>Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, Ganesh SK, Gulati R, Lindsay ME, Mieres JH, Naderi S, Shah S, Thaler DE, Tweet MS, Wood MJ; American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation. 2018 May 8;137(19):e523-e557. doi: 10.1161/CIR.0000000000000564. Epub 2018 Feb 22. Review.</citation>
    <PMID>29472380</PMID>
  </reference>
  <reference>
    <citation>Adlam D, Alfonso F, Maas A, Vrints C; Writing Committee. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. Eur Heart J. 2018 Sep 21;39(36):3353-3368. doi: 10.1093/eurheartj/ehy080.</citation>
    <PMID>29481627</PMID>
  </reference>
  <reference>
    <citation>Waterbury TM, Tweet MS, Hayes SN, Eleid MF, Bell MR, Lerman A, Singh M, Best PJM, Lewis BR, Rihal CS, Gersh BJ, Gulati R. Early Natural History of Spontaneous Coronary Artery Dissection. Circ Cardiovasc Interv. 2018 Sep;11(9):e006772. doi: 10.1161/CIRCINTERVENTIONS.118.006772.</citation>
    <PMID>30354594</PMID>
  </reference>
  <reference>
    <citation>Tweet MS, Eleid MF, Best PJ, Lennon RJ, Lerman A, Rihal CS, Holmes DR Jr, Hayes SN, Gulati R. Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circ Cardiovasc Interv. 2014 Dec;7(6):777-86. doi: 10.1161/CIRCINTERVENTIONS.114.001659. Epub 2014 Nov 18.</citation>
    <PMID>25406203</PMID>
  </reference>
  <reference>
    <citation>Tweet MS, Hayes SN, Codsi E, Gulati R, Rose CH, Best PJM. Spontaneous Coronary Artery Dissection Associated With Pregnancy. J Am Coll Cardiol. 2017 Jul 25;70(4):426-435. doi: 10.1016/j.jacc.2017.05.055.</citation>
    <PMID>28728686</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2019</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Marysia Tweet</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>spontaneous coronary artery dissection</keyword>
  <keyword>autoimmune</keyword>
  <keyword>incidence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Dermatomyositis</mesh_term>
    <mesh_term>Polymyositis</mesh_term>
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Celiac Disease</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
    <mesh_term>Hepatitis, Autoimmune</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Myasthenia Gravis</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Guillain-Barre Syndrome</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Graves Disease</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Anemia, Pernicious</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Vitiligo</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Thyroiditis</mesh_term>
    <mesh_term>Hashimoto Disease</mesh_term>
    <mesh_term>Addison Disease</mesh_term>
    <mesh_term>Antiphospholipid Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

